Tenet Healthcare is facing a tough sentiment apparatus for hospitals and broader services, which may temporarily hamper its price multiple. However, with a strong track record of managing uncertainty and potential upside in 2Q reporting, combined with stable long-term value drivers such as growth in its specialty hospitals and strategic capital deployment, the stock is currently undervalued and maintains a BUY rating.
Bears say
Tenet Healthcare is experiencing declining admissions and increasing expenses, with 1Q26 adjusted EBITDA down 0.1% year over year and 2026 guidance for both revenue and adjusted EBITDA reaffirmed. Its management is also facing cost efficiency challenges and a decreasing managed care payer mix, contributing to a negative outlook on the stock.
Tenet Healthcare (THC) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 58% recommend Buy, 5% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Get the latest Tenet Healthcare (THC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.
According to 19 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $239.47, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $239.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.
Get the latest Tenet Healthcare (THC) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.